All American Career College Vascular Neurocognitive Disorder Treatment Discussion Discussion: Treatment of Neurocognitive Disorders: VASCULAR NEUROCOGNITI

All American Career College Vascular Neurocognitive Disorder Treatment Discussion Discussion: Treatment of Neurocognitive Disorders:

VASCULAR NEUROCOGNITIVE DISORDER

Neurocognitive disorders (NCD) such as delirium, dementia, and amnestic disorders are more prevalent in older adults. As the population ages and as life expectancy in the United States continues to increase, the incidence of these disorders will continue to increase. Cognitive functioning such as memory, language, orientation, judgment, and problem solving are affected in clients with NCDs. Caring for someone with a neurocognitive disorder is not only challenging for the clinician, but also stressful for the family. The PMHNP needs to consider not only the client but also the “family as client.” Collaboration with primary care providers and specialty providers is essential. Anticipatory guidance also becomes extremely important.

In this Discussion, you will integrate several sources of knowledge specific to NCDs as you discuss evidenced-based therapies used to treat these disorders.

Analyze diagnostic criteria for neurocognitive disorders

Analyze evidence-based psychotherapy and psychopharmacologic treatment for neurocognitive disorders

Evaluate benefits and risks of neurocognitive therapies

Compare differential diagnostic features of neurocognitive disorders

To prepare for this Discussion:

Explain the diagnostic criteria for your assigned neurocognitive disorder.

Explain the evidenced-based psychotherapy and psychopharmacologic treatment for your assigned neurocognitive disorder.

Identify the risks of different types of therapy and explain how the benefits of the therapy that might be achieved might outweigh the risks.

Support your rationale with 3 or more current references or other academic resource.

Required Readings

Acadia Pharmaceuticals. (2017). Transform the treatment of Parkinson’s disease psychosis with NUPLAZID. Retrieved from https://www.nuplazidhcp.com/?gclid=CIHS5auvwtMCFQkaaQodrU0FGQ

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.

Gabbard, G. O. (2014). Gabbard’s treatment of psychiatric disorders (5th ed.). Washington, DC: American Psychiatric Publications.

Hopkins, S. A., & Chan, D. (2016). Key emerging issues in frontotemporal dementia. Journal of Neurology, 263(2), 407–413. doi:10.1007/s00415-015-7880-7

Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer.

Chapter 21, “Neurocognitive Disorders” (pp. 694–741)